SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as the community reacts to an upcoming CEO appearance on Fox & Friends, fueling speculation about potential catalysts like the 80th clinical trial event or a possible partnership. Investors are actively debating the significance of recent peer-reviewed AML survival data, which many view as a strong validation of the company's treatment efficacy against current standards of care.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing heightened volatility as investors weigh a strong earnings beat and positive outlook against broader market concerns regarding escalating capital expenditure in the semiconductor sector. The community remains deeply divided, with many traders debating whether the stock's recent price action signals a long-term turnaround supported by AI demand or a temporary rally vulnerable to further profit-taking.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending as investors react to a significant patent extension for Miplyffa that extends exclusivity to 2041, triggering a wave of bullish analyst upgrades and price target revisions. The community is actively discussing the stock's breakout potential and its strengthening position as a rare disease player, with many shareholders focused on long-term value despite historical volatility.

Verizon Communications, Inc. is a holding company, which engages in the provision of communications, information, and entertainment products and services. It operates through the Consumer and Business segments. The Consumer segment provides consumer-focused wireless and wire line communications services and products. The Business segment offers wireless and wireline communications services and products, including FWA broadband, data, video and conferencing services, corporate networking solutions, security and managed network services, local and long-distance voice services, and network access to deliver various IoT services and products. The company was founded in 1983 and is headquartered in New York, NY.

Verizon Communications Inc

Verizon Communications Inc.

Verizon is trending as investors digest the company's latest earnings report, which featured an adjusted profit beat and raised full-year guidance despite a headline profit decline due to restructuring costs. Community discussion centers on the stock's dividend stability, share repurchases, and the potential for long-term growth driven by AI infrastructure and subscriber gains.

Charter Communications, Inc. engages in providing broadband communications services. Its services include Spectrum TV, Spectrum Internet, and Spectrum Voice. It offers business-to-business Internet access, data networking, business telephone, video and music entertainment services, and wireless backhaul. Its advertising sales division, Spectrum Reach, offers local, regional, and national businesses the opportunity to advertise in individual and multiple service areas on cable television networks and advanced advertising platforms. The company was founded in 1993 and is headquartered in Stamford, CT.

Charter Communications Inc. - Ordinary Shares - Class A

Charter Communications is currently trending due to intense volatility and heightened investor scrutiny ahead of earnings, fueled by a sharp divergence between bearish sentiment regarding customer churn and bullish arguments centered on a high buyback yield and attractive valuation. The community remains deeply divided, with aggressive short-sellers targeting the stocks downward momentum while value-focused investors argue that the company's free cash flow and share reduction strategies are being severely mispriced.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health Inc. is trending as investors react to an FDA advisory committee's decision to recommend several peptides for inclusion on the compounding list, fueling excitement about the company's potential to expand its wellness and growth offerings. The community is actively debating the significance of these regulatory updates, with strong discourse centered on the stock's high short interest and the potential for a short squeeze despite skepticism from notable critics.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as traders debate whether massive, unusual trading volume signals institutional accumulation or continued market manipulation. The community is focused on the tension between significant short interest and the company's strategic pivot toward agentic AI orchestration, with many investors closely monitoring key technical levels for a potential breakout.

MaxLinear, Inc. engages in the provision of communications systems-on-chip (SoC) solutions used in broadband, mobile and wireline infrastructure, data center, and industrial and multi-market applications. Its products include cable broadband modems and gateways, wireline connectivity devices, radio frequency transceivers, fiber-optic modules, video set-top boxes and gateways, hybrid analog and digital televisions, direct broadcast satellite outdoor and indoor units, and power management and interface products. The company was founded by Kimihiko Imura, Curtis C. Ling, and Kishore V. Seendripu on September 25, 2003 and is headquartered in Carlsbad, CA.

MaxLinear Inc

MaxLinear is currently trending as investors react to a significant earnings beat and robust guidance driven by accelerating demand for optical data center infrastructure. The community is actively debating the stock's valuation and volatility, with many traders closely monitoring the momentum-driven price action and the impact of the company's expanding AI-focused product portfolio.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is facing intense volatility following a weak earnings report, with the community actively debating whether the double-digit percentage drop represents a bottoming opportunity or the start of a deeper fundamental decline. Investors remain sharply divided between those calling for a technical bounce driven by market-maker hedging and those concerned that the company's aggressive spending on AI and robotics is outpacing near-term profit potential.

Deckers Outdoor Corp. engages in the business of designing, marketing, and distributing footwear, apparel, and accessories developed for both everyday casual lifestyle use and high performance activities. It operates through the following segments: UGG Brand, HOKA Brand, Teva Brand, Sanuk Brand, Other Brands, and Direct-to-Consumer. The UGG Brand segment offers a line of premium footwear, apparel, and accessories. The HOKA Brand segment sells footwear and apparel that offers enhanced cushioning and inherent stability with minimal weight, originally designed for ultra-runners. The Teva Brand segment focuses on the sport sandal and modern outdoor lifestyle category, such as sandals, shoes, and boots. The Sanuk Brand segment originated in Southern California surf culture and has emerged into a lifestyle brand with a presence in the relaxed casual shoe and sandal categories. The Other Brands segment includes the Koolaburra by UGG brand. The Direct-to-Consumer segment consists of retail stores and e-commerce websites. The company was founded by Douglas B. Otto in 1973 and is headquartered in Goleta, CA.

Deckers Outdoor Corp.

Deckers Outdoor is trending as investors react to strong fiscal Q1 earnings and raised guidance, fueled by robust demand for its HOKA and UGG brands. While the results beat expectations, the stock's price action remains volatile as the community debates whether the guidance is conservative enough and if concerns over slowing growth justify the current sell-off.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cigna Healthcare Expands AI-Enabled Personalized Support to Help More Customers Access Care Earlier and Improve Affordability

Cigna Healthcare Expands AI-Enabled Personalized Support to Help More Customers Access Care Earlier and Improve Affordability Cigna Healthcare Expands AI-Enabled Personalized Support to Help More Customers Access Care Earlier and Improve Affordability PR Newswire BLOOMFIELD, Conn., July 23, 2026...

The Cigna Group Declares Quarterly Dividend

The Cigna Group Declares Quarterly Dividend The Cigna Group Declares Quarterly Dividend PR Newswire BLOOMFIELD, Conn., July 22, 2026 BLOOMFIELD, Conn., July 22, 2026 /PRNewswire/ -- TheBoard of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.56 per share of its common...

Why Cigna (CI) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Independent Pharmacies Accuse Prime Therapeutics of Price-Fixing Scheme With Express Scripts

Nearly 5,000 independent pharmacies sue Prime Therapeutics for antitrust violations & price-fixing with Cigna's Express Scripts.read more...

Here's Why Cigna (CI) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

The Cigna Group's Second Quarter 2026 Earnings Release Details

The Cigna Group's Second Quarter 2026 Earnings Release Details The Cigna Group's Second Quarter 2026 Earnings Release Details PR Newswire BLOOMFIELD, Conn., July 7, 2026 BLOOMFIELD, Conn., July 7, 2026 /PRNewswire/ --Global health company The Cigna Group (NYSE:CI) will release its second quarter...

UnitedHealth Bets on Profitability Over Growth: Will It Pay Off?

UnitedHealth is prioritizing profitability over rapid growth as improving margins, stronger earnings and Optum expansion aim to support a long-term turnaround.

Cigna Brings AI to Specialty Pharmacy With Pharmacy Forward

Cigna's Evernorth launched AI-powered Pharmacy Forward to speed up specialty prescriptions, cut delays and boost efficiency with a $100M investment.

Evernorth Launches Pharmacy Forward: A Simpler, Faster Specialty Pharmacy Experience for Patients Managing Complex Conditions

Evernorth Launches Pharmacy Forward: A Simpler, Faster Specialty Pharmacy Experience for Patients Managing Complex Conditions Evernorth Launches Pharmacy Forward: A Simpler, Faster Specialty Pharmacy Experience for Patients Managing Complex Conditions PR Newswire BLOOMFIELD, Conn., July 1, 2026 New...

Can Cigna's Expansion Beyond Health Insurance Fuel Long-Term Growth?

CI is evolving beyond traditional insurance, using AI, specialty pharmacy and healthcare services to drive growth and sharpen its business focus.

The Cigna Group is a global health company, which engages in the provision of global health services. It operates through the following segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment partners with health plans, employers, governmental organizations, and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. The Cigna Healthcare segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. The company was founded in 1792 and is headquartered in Bloomfield, CT.

Cigna Group (The)

OSCR Stock Hits 5-Year High: Oscar Sees 'Healthy Tailwinds' In 2026 On Potential Upside To Guidance

Equity

Neutral Sentiment

Track CI stock price, charts, news and real-time market activity on Stocktwits. Join the CI message board to follow investor discussions, retail trader sentiment, bullish and bearish signals around Cigna Corp stock.

CI Stock Price Today - Cigna Corp News, Charts, Retail Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

CICigna Corp.

Fundamentals

Latest CI News